Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Untreated epidermolysis bullosa acquisita can cause total hair and nail loss.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

KID syndrome should be reclassified as an ectodermal dysplasia.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

EFFC might be common but underreported.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Oral zinc therapy is effective for treating acrodermatitis enteropathica.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Higher inflammation markers are linked to more severe alopecia areata.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Rash in SLE patients indicates more severe disease.

Doctors should consider comedonic discoid lupus erythematosus to avoid misdiagnosis.

The document concludes that the acoustic coupler SF-001 is good for skin ultrasound, especially on rough body parts, because it's stable and shows blood vessels well.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Upadacitinib effectively treats severe alopecia areata and is safe.